Lipella Pharmaceuticals Inc. Stock
Stocks
LIPO
US53630L2097
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0800 USD | -21.57% |
|
+144.65% | -55.56% |
| Market Cap | 832K 731K 679K 623K 1.17M 80.1M 1.19M 8.07M 3.15M 39.38M 3.12M 3.06M 136M | P/E 2023 |
-1.32x | P/E 2024 | -0.64x |
|---|---|---|---|---|---|
| Enterprise Value | -1.31M -1.15M -1.07M -979K -1.84M -126M -1.87M -12.66M -4.95M -61.81M -4.9M -4.8M -214M | EV / Sales 2023 |
6.14x | EV / Sales 2024 | 2.89x |
| Free-Float |
93.69% | Yield 2023 * |
-
| Yield 2024 | - |
| 25-02-11 | Top Midday Gainers | MT |
| 24-04-09 | Maxim Initiates Lipella Pharmaceuticals at Buy Rating With $2 Price Target | MT |
| 1 day | -21.57% | ||
| 1 week | +144.65% | ||
| Current month | -30.25% | ||
| 1 month | -11.11% | ||
| 3 months | +160.59% | ||
| 6 months | -54.80% | ||
| Current year | -55.56% |
| 1 month | 0.03 |  | 0.13 |
| Current year | 0.02 | | 0.32 |
| 1 year | 0.02 | | 0.78 |
| 3 years | 0.02 | | 21.68 |
| 5 years | 0.02 | | 61.76 |
| 10 years | 0.02 | | 61.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Kaufman
CEO | Chief Executive Officer | 60 | 2004-12-31 |
Douglas Johnston
DFI | Director of Finance/CFO | 42 | 2021-09-30 |
Janet Okonski
CTO | Chief Tech/Sci/R&D Officer | - | 2021-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Kaufman
CHM | Chairman | 60 | 2004-12-31 |
Byong Kim
BRD | Director/Board Member | 55 | 2022-02-28 |
Ryan Pruchnic
BRD | Director/Board Member | 53 | 2021-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/3/25 | Others | Chief Executive Officer | 695,776 | 27.2981% | ||
| 3/13/25 | Others | Chief Executive Officer | 14,386 | 0.5644% | ||
| 3/10/25 | Others | Chief Executive Officer | 28,924 | 1.1348% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -21.57% | +144.65% | -87.24% | -99.53% | 151K | |
| +0.93% | +6.97% | +59.60% | +69.78% | 57.28B | |
| -1.92% | +6.03% | +40.64% | +80.66% | 54.99B | |
| -0.46% | -1.29% | +2.86% | +425.15% | 23.18B | |
| -2.97% | -2.35% | -22.53% | -15.34% | 22.59B | |
| -0.36% | +5.73% | +24.13% | -7.02% | 20.46B | |
| -1.34% | +0.51% | +26.03% | -28.68% | 17.56B | |
| -1.44% | +5.67% | +38.77% | +565.80% | 15.67B | |
| -1.30% | -5.02% | +170.77% | +310.94% | 14.46B | |
| -0.50% | -0.98% | +21.43% | +179.36% | 13.92B | |
| Average | -3.09% | +1.15% | +27.45% | +148.11% | 24.01B | |
| Weighted average by Cap. | -0.87% | +2.10% | +39.70% | +138.06% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 450K 395K 367K 337K 633K 43.3M 643K 4.36M 1.7M 21.29M 1.69M 1.65M 73.6M | 536K 471K 438K 402K 755K 51.65M 767K 5.2M 2.03M 25.39M 2.01M 1.97M 87.8M |
| Net income | -4.62M -4.06M -3.77M -3.46M -6.5M -445M -6.61M -44.8M -17.5M -219M -17.34M -16.97M -756M | -5.02M -4.41M -4.1M -3.76M -7.06M -483M -7.17M -48.65M -19.01M -237M -18.83M -18.43M -821M |
| Net Debt | -3.16M -2.77M -2.58M -2.37M -4.45M -304M -4.51M -30.62M -11.96M -149M -11.85M -11.6M -517M | -2.14M -1.88M -1.75M -1.6M -3.01M -206M -3.06M -20.73M -8.1M -101M -8.02M -7.85M -350M |
Employees
6
| Date | Price | Change | Volume |
|---|
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LIPO Stock
Select your edition
All financial news and data tailored to specific country editions
